Show
Sort by
-
Clinical characteristics and outcomes of children with stage 3-5 chronic kidney diseaese
-
Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951
-
Presentation and outcome of children with down syndrome and acute lymphoblastic leukemia in the eortc children's leukemia group protocol 58951
-
A prognostic index for progression-free survival in malignant mesothelioma with application to the design of phase II trials: a combined analysis of 10 EORTC trials
-
Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: Long term results of the EORTC CLG 58881 trial
-
Improved outcome with pulses of Vincristine (VCR) and Steroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and Non Hodgkin Lymphoma (NHL): final report of the EORTC randomized phase III trial 58951
-
Progression-free survival rate as primary end point for phase II cancer clinical trials: Application to mesothelioma - The EORTC Lung Cancer Group
-
Prognostic significance of blasts with/without pleiocytosis in the cerebro-spinal fluid (CSF) of children with acute lymphoblastic leukemia (ALL) treated without cranial irradiation: results of European Organization for Research and Treatment of Cancer (EORTC) children leukemia group study 58881
-
STAT3, TFF3, VEGFR in colon cancer cells (vol 65, pg 165, 2005)
-
- Journal Article
- A1
- open access
A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemias